SCHEMBL7801693

SCHEMBL7801693

COc1cc2nc(N)nc(-c3cccc(C(F)(F)F)c3)c2cc1OC

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.50
ABCG2 Q9UNQ0 3/20 0.50
ADORA1 P30542 2/20 0.50
WHR1 P49842 1/20 0.49
RORB Q92753 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
KRAS P01116 1/20 0.47
SOS1 Q07889 1/20 0.47
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
EGFR P00533 4/20 0.46
PDE4B Q07343 2/20 0.45
CSF1R P07333 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7801624 0.83 ADORA2A (0.56) ADORA2AADORA1WHR1EGFRPDE4B
SCHEMBL30759714 0.82 WHR1 (0.71) ADORA2AADORA1WHR1NPSR1KDM4E
SCHEMBL1257435 0.82 WHR1 (0.71) ADORA2AADORA1WHR1NPSR1KDM4E
SCHEMBL5793277 0.81 PDE4A (0.54) ADORA2AADORA1WHR1EGFRPDE4B
SCHEMBL1942672 0.81 EGFR (0.61) ADORA2AABCG2WHR1KRASSOS1
SCHEMBL7800408 0.81 WHR1 (0.52) ADORA2AWHR1EGFRPDE4B
SCHEMBL7799250 0.77 ADORA2A (0.53) ADORA2AADORA1WHR1EGFR
SCHEMBL16502038 0.76 ABCG2 (0.52) ADORA2AABCG2WHR1ALDH1A1PDE4B
SCHEMBL29470281 0.74 PDE4A (0.55) ADORA2AADORA1WHR1KDM4EALDH1A1
SCHEMBL7666280 0.74 HSP90AB1 (0.58) ADORA2AADORA1WHR1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1162974-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
EP-1163228-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
WO-2000056338-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed
WO-2000056720-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed